CUSIP: 45166R204
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
105,769,012
-
Share change
-
+433,703
-
Total reported value
-
$632,210,093
-
Put/Call ratio
-
39%
-
Price per share
-
$5.98
-
Number of holders
-
90
-
Value change
-
+$2,728,000
-
Number of buys
-
1
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 45166R204?
CUSIP 45166R204 identifies IDIX - IDENIX PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2014
-
Previous quarter:
Q3 2013
Recent filing periods for CUSIP 45166R204:
Institutional Holders of IDENIX PHARMACEUTICALS INC - COM (IDIX) as of Q4 2013
As of 31 Dec 2013,
IDENIX PHARMACEUTICALS INC - COM (IDIX) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,769,012 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, BROOKSIDE CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Sarissa Capital Management LP, State Street Corp, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., Cormorant Asset Management, LLC, and BRIDGER MANAGEMENT, LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.